New State of the Art Laboratory Opens in Brisbane

Congratulations to 360biolabs, a BioAgilytix company, on opening their new, expanded state-of-the-art laboratory and capabilities in Brisbane.

We love having them close by our offices in the Translational Research Institute Australia building, where the lab fits right into the bench-to-bedside philosophy that exists within the TRI and Princess Alexandra Hospital precinct, with its collaborative mindset between academia, industry and clinicians.

Angela Luttick gave us a sneak peak of the new lab, which gives the BioAgilytix team expanded capacity to process time-sensitive samples for PBMC isolation plus flow cytometry, and offer extended biomarker profiling, PK ELISA and central lab services. The Brisbane lab can support large molecule, advanced modality and vaccine clinical trials under ISO/IEC 17025, GCP and GCLP, allowing acceptance of data from globally regulatory bodies.

It’s great to see the Queensland Life Sciences sector supporting such expansion, and we can't wait to see what innovations come out of this amazing lab.